Market cap
₹408 Cr
Revenue (TTM)
₹156 Cr
P/E Ratio
33.6
P/B Ratio
3.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹8 Cr
-
ROE
9.3 %
-
ROCE
13.2 %
-
Industry P/E
39.7
-
EV/EBITDA
17.9
-
Debt to Equity
0.5
-
Book Value
₹70.2
-
EPS
₹5.2
-
Face value
10
-
Shares outstanding
15,583,120
6 Years Aggregate
CFO
₹6.50 Cr
EBITDA
₹68.52 Cr
Net Profit
₹39.45 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Infinium
| 17.4 | 25.5 | 22.4 | 3.6 | -0.4 | -- | -- |
|
BSE Healthcare
| 18.1 | 1.0 | 9.6 | 17.6 | 22.5 | 14.1 | 12.2 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Infinium
| -27.4 | 30.8 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Infinium
|
261.7 | 407.8 | 155.7 | 7.8 | -- | 9.3 | 33.6 | 3.7 |
| 3,174.3 | 25,979.8 | 1,461.8 | 387.4 | 34.5 | 25.2 | 67.3 | 15.1 | |
| 843.9 | 16,595.8 | 7,784.0 | 688.5 | 10.6 | 14 | 23.9 | 2.8 | |
| 460.0 | 17,589.9 | 2,141.5 | 58.5 | 5.8 | 3.3 | 165.6 | 4.6 | |
| 837.2 | 20,755.5 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.3 | 4.2 | |
| 1,527.9 | 17,502.0 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 213.2 | 28,384.3 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.5 | |
| 1,822.2 | 30,127.6 | 1,935.8 | 288.2 | 20.6 | 29.8 | 104.5 | 22.4 | |
| 402.1 | 16,213.4 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.4 | 3.4 | |
| 1,850.6 | 30,074.9 | 3,564.0 | 414.0 | 15.3 | 8.4 | 73.5 | 6.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Infinium
Manufacture of pharmaceuticals, medicinal chemical and botanical products
-
Incorporated
2003
-
Chairman
--
-
Managing Director
Sanjay Kumar Patel
-
Headquarters
Anand Dist, Gujarat
-
Website
Looking for more details about Infinium Pharmachem Ltd.’s IPO? Explore our IPO Details page.
FAQs for Infinium
What is the current share price of Infinium Pharmachem Ltd Today?
The share price of Infinium Pharmachem Ltd is ₹261.70 (NSE) as of 01-Sep-2026 IST. Infinium Pharmachem Ltd has given a return of -0.41% in the last 3 years.
What is the current PB & PE ratio of Infinium Pharmachem Ltd?
The P/E ratio of Infinium Pharmachem Ltd is 33.56 times as on 01-Sep-2026, a 15 discount to its peers’ median range of 39.70 times.
The P/B ratio of Infinium Pharmachem Ltd is 3.73 times as on 01-Sep-2026, a 0 premium to its peers’ median range of 3.72 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
46.28 |
3.44 |
2024 |
28.20 |
5.42 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
2021 |
0.00 |
0.00 |
What is the 52 Week High and Low of Infinium Pharmachem Ltd?
The 52-week high and low of Infinium Pharmachem Ltd are Rs 282.90 and Rs 189.40 as of 01-Sep-2026.
What is the market cap of Infinium Pharmachem Ltd?
Infinium Pharmachem Ltd has a market capitalisation of ₹ 408 Cr as on 01-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Infinium Pharmachem Ltd?
Before investing in Infinium Pharmachem Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.